-
CSR Summary Not Available
-
NCT03434041 Not Available
-
Primary Citation Trial has yet to be published
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameEsketamineProduct NameSPRAVATO®Therapeutic AreaNervous System DiseasesEnrollment252% FemaleN/A% WhiteN/A
Product ClassNMDA receptor antagonistSponsor Protocol NumberESKETINTRD3006Data PartnerJohnson & JohnsonCondition StudiedDepressive Disorder, Treatment-ResistantMean/Median Age (Years)37.3
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available